Literature DB >> 27003255

MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration.

Jiaxiu Xiong1, Bo Wei2, Qinong Ye3, Wenzhong Liu4.   

Abstract

Aberrant expression of ubiquitin Protein ligase E3C (UBE3C) has been documented in breast cancer (BC). MicroRNAs (miRNAs) were shown to play an important role in the regulation of tumor properties in BC. However, whether miRNAs contributes to UBE3C expression in BC cells remains poorly understood. In this study, we report that UBE3C was a direct target of miR-30a-5p. Expression of miR-30a-5p in BC cells reduced UBE3C expression. MCF-7 and MDA-MB-453 cells were transfected miR-30a-5p-overexpression, and found that cell proliferation and migration were inhibited. In contrast, when miR-30a-5p inhibitor were transfected into MCF-7 and MDA-MB-453 cells, cell proliferation and migration were promoted. We study demonstrated that upregulation of miR-30a-5p was significantly suppressed levels of cyclin B1, cyclin D1 and c-myc. Moreover, Correlation analysis indicated that expression of miR-30a-5p was highly negatively correlated with UBE3C, which was upregulated in BC specimens. These data highlight the important role of miR-30a-5p/UBE3C axis in BC development and progression. Therefore, miR-30a-5p activation or UBE3C inhibition may be provide a novel strategy for the treatment of BC.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; MiR-30a-5p; Proliferation and migration; UBE3C; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27003255     DOI: 10.1016/j.bbrc.2016.03.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Interrelation of androgen receptor and miR-30a and miR-30a function in ER-, PR-, AR+ MDA-MB-453 breast cancer cells.

Authors:  Shuhua Lyu; Han Liu; Xia Liu; Shan Liu; Yahong Wang; Qi Yu; Yun Niu
Journal:  Oncol Lett       Date:  2017-08-21       Impact factor: 2.967

2.  MicroRNA-30a-5p (miR-30a) regulates cell motility and EMT by directly targeting oncogenic TM4SF1 in colorectal cancer.

Authors:  Y R Park; S L Kim; M R Lee; S Y Seo; J H Lee; S H Kim; I H Kim; S O Lee; S T Lee; Sang Wook Kim
Journal:  J Cancer Res Clin Oncol       Date:  2017-05-20       Impact factor: 4.553

3.  MiR-30a-5p hampers proliferation of lung squamous cell carcinoma through targeting FBXO45.

Authors:  Fanye Zeng; Shuqing You; Xueli Dai
Journal:  Histol Histopathol       Date:  2022-01-31       Impact factor: 2.303

4.  Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.

Authors:  Zhipeng Xu; Shuqiu Chen; Ruiji Liu; Hui Chen; Bin Xu; Weizhang Xu; Ming Chen
Journal:  Mol Cancer       Date:  2022-07-15       Impact factor: 41.444

5.  Overexpression of suppressive microRNAs, miR-30a and miR-200c are associated with improved survival of breast cancer patients.

Authors:  Tsutomu Kawaguchi; Li Yan; Qianya Qi; Xuan Peng; Emmanuel M Gabriel; Jessica Young; Song Liu; Kazuaki Takabe
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

6.  MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells.

Authors:  Yueh-Hua Chung; Sung-Chou Li; Ying-Hsien Kao; Hao-Lun Luo; Yuan-Tso Cheng; Pey-Ru Lin; Ming-Hong Tai; Po-Hui Chiang
Journal:  Int J Mol Sci       Date:  2017-08-22       Impact factor: 5.923

7.  miR‑30a‑5p inhibits hypoxia/reoxygenation‑induced oxidative stress and apoptosis in HK‑2 renal tubular epithelial cells by targeting glutamate dehydrogenase 1 (GLUD1).

Authors:  Yangbiao He; Xujun Lang; Dong Cheng; Ting Zhang; Zhihao Yang; Rongbing Xiong
Journal:  Oncol Rep       Date:  2020-08-07       Impact factor: 3.906

Review 8.  MiR-30a: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Lin-Hong Jiang; He-da Zhang; Jin-Hai Tang
Journal:  J Oncol       Date:  2018-08-06       Impact factor: 4.375

9.  MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9.

Authors:  Lining Jiang; Yabin Liu; Can Ma; Binghui Li
Journal:  Oncol Lett       Date:  2018-06-20       Impact factor: 2.967

10.  Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.

Authors:  Jeremy T-H Chang; Fan Wang; William Chapin; R Stephanie Huang
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.